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Preface 
This is the report of the eleventh of a series 
of workshops organised by the European 
Centre for the Validation of Alternative 
Methods (ECVAM), which was established in 
1991 by the European Commission. 
ECVAM's main goal, as defined in 1993 by 
its Scientific Advisory Committee, is to pro-
mote the scientific and regulatory acceptance 
of alternative methods which are of impor-
tance to the biosciences and which reduce, 
refine or replace the use of laboratory ani-
mals. One of the first priorities set by 
Eev AM was the implementation of proce-
dures which would enable it to become well-
informed about the state-of-the-art of 
non-animal test development and validation. 
and the potential for the possible incorpora-
tion of replacement alternative tests into 
regulatory procedures. It was decided that 
this would be best achieved by the organisa-
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tion of ECV AM workshops on specific topics, 
at which small groups of invited experts 
would review the current status of various 
types of in vitro tests and their potential 
uses, and make recommendations about the 
best ways forward (1). 
The workshop on The Three Rs - The 
Way Forward, held in Sheringham, Norfolk, 
UK, on 30 May to 3 June 1995, under the co-
chairmanship of Michael Balls (ECVAMI and 
Alan M. Goldberg (Johns Hopkins Center for 
Alternatives to Animal Testing [CAAT], 
Baltimore, MD, USAI, had a wider aim. The 
principal objectives of this workshop were to 
discuss the current status of the Three Rs, 
and to make recommendations aimed at 
achieving greater acceptance of the concept 
of humane experimental technique and, in 
the interests of both scientific excellence and 
the highest standards of animal welfare, the 
more active implementation of reduction 
alternatives, refinement alternatives and 
replacement alternatives. 
The invited participants were individuals 
actively and professionally committed to the 
Three Rs, and we were privileged to have 
William Russell and Rex Burch, who devel-
oped the Three Rs approach in the 1950s, as 
participants in the workshop. 
The opening ceremony was held in 
Sheringham Town Hall, where Rex Burch 
has practised as a microbiologist since the 
early 1970s. Since this was the first time that 
Russell and Burch had attended a scientific 
conference together for nearly forty years, 
the proceedingfi were recorded on videotape 
(the VHS tape can be borrowed from 
ECV AM and a JVC version is available from 
CAATI. The rest of the workshop was held at 
the Links Country Park Hotel, West Runton. 
Introduction 
The origins of the Three Rs concept 
What are now known as the Three Rs of 
Russell and Burch, replacement, reduction 
and refinement, have their origins in a pro-
posal made in 1954 by Charles Hume, 
founder of the Universities Federation for 
Animal Welfare tUFAWI, that UFAW should 
undertake a scientific study of humane tech-
nique in laboratory animal experiments. The 
M. Balls et ai. 
project was managed by a committee under 
the chairmanship of Sir Peter Medawar, 
with William Lane-Petter, Secretary of the 
Research Defence Society, among its mem-
bers. It was international from its outset, 
since Christine Stevens, of the Animal 
Welfare Institute (AWl) in the USA, pro-
vided financial support and made frequent 
visits to UF AW while the study was being 
conducted. 
W.M.S. Russell and R.L. Burch were 
appointed to carry out the work. This led to 
their book, The Principles of Humane 
Experimental Techniq'le (2), which provided 
a wealth of information and many remark-
able ideas and insights, most of them as rel-
evant today as they were more than 35 years 
ago. The book has recently been reprinted 
(31, and copies can be obtained from UFAW.' 
It was in this book that Russell and Burch 
presented the concept of the Three Rs. They 
defined replacement as "any scientific 
method employing non-sentient material 
which may in the history of animal experi-
mentation replace methods which use con-
scious living vertebrates", reduction as a 
means of lowering "the number of animals 
used to obtain information of a given amount 
and precision", and refinement as any devel-
opment leading to a "decrease in the inci-
dence or severity of inhumane procedures 
applied to those animals which have to be 
used". 
Nobody can recall precisely when the 
Three Rs concept arose (4), but it was some-
time between 1955 and 1957. UFAW held a 
symposium on Humane Technique in the 
LaboratolY (51 in 1957, and it was then that 
the concept of the Three Rs was first dis-
cussed in public. More about the origins of 
the Three Rs concept can be found in a talk 
given by Charles Hume in Washington in 
October 1959 (61, when he said of The 
Principles of Humane Experimental 
Technique: 
"This deserves to become a classic for all 
time, and we have great hopes that it will 
inaugurate a new field of systematic study. 
We hope that others will follow up the lead it 
has given, and that a generalised study of 
humane technique, as a systematic compo· 
nent of the methodology of research, will 
come to be considered essential to the train-
18 Hamilton Close, Softth Mimms, Poilen; Bar, Herts, EN6.'JQD, UK. 
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ing of a biologist." 
What is perhaps the central message (the 
"humanity criterion") of The Principles of 
Humane Experimental Techiqlle (2) is 
spelled out on page 157 of the book: 
"If we are to use a criterion for choosing 
experiments to perform, the criterion of 
humanity is the best we could possibly 
invent." 
"The greatest scientific experiments have 
always been the most humane and the most 
aesthetically attractive, conveying that sense 
of beauty and elegance which is the essence 
of science at its most successful." 
The evolution of the Three Rs concept 
Despite its originality and scholarship, and 
the involvement of many distinguished sci· 
entists in the discussions leading up to its 
publication, Russell and Burch's book had 
little obvious impact on thinking or practice 
in the early years after its publication. In 
fact, its authors did not meet each other 
again for about 30 years, when they were 
"rediscovered" by a new generation of 
reformers. 
However, in 1969, one particularly signifi· 
cant development did take place - the foun-
dation by Dorothy Hegarty of the Fund for 
the Replacement of Animals in Medical 
Experiments (FRAME), specifically to 
advance Russell and Burch's vision that 
humanitarian and scientific benefits would 
result from the systematic and rational 
application of the Three Rs approach. 
FRAME saw reduction and refinement as' 
achievable in the short term, but decided to 
focus its own activities primarily on replace-
ment as the ultimate, long-term goal (7). 
FRAME was to succeed in establishing itself 
in the middle ground between the antivivi-
sectionists and the defenders of animal· 
based research, with a positive message, 
based not on confrontation, but on support 
of the Three Rs concept. 
In the 1970s, there were a number of other 
significant events. For example, there was a 
substantial increase in laboratory animal use 
in the early part of the decade, which led to 
great public concern in Great Britain, and an 
Animal Welfare Year campaign, involving 
many animal welfare organisations, was 
organised to mark the centenary of the 
Cruelty to Animals Act 1876 (8), the law 
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under which experiments on animals were 
allowed and regulated. This led in turn to the 
formation of the Committee for the ,Reform 
of Animal Experimentation (CRAE), which 
had as its principal goal the reform of the 
1876 Act (9). The concept of alternatives was 
also taking hold in the USA. as a result oflhe 
efforts of the AWl (who distributed Russell 
and Burch's book), United Action for 
Animals, and the Humane Society of the 
United States. 
Meanwhile, David Smyth, a distinguished 
physiologist, was conducting a survey on the 
Three Rs for the Research Defence Society, 
which led to another important landmark, 
the publication of his book on Alternatives to 
Animal Experiments (10). Smyth provided a 
Three Rs definition of alternatives, which 
has since been widely accepted: 
"All procedures which can completely 
replace the need for animal experiments, 
reduce the numbers of animals required, or 
diminish the amount of pain or distress suf-
fered by animals in meeting the essential 
needs of man and other animals." 
A number of particularly important 
changes began to take place at the beginning 
of the 1980s. In the USA, animal activist 
Henry Spira launched a campaign to abolish 
the Draize eye irritancy test, with the world-
wide support of a coalition of 400 animal 
organisations. In Europe, discussions began 
which were later to lead to the Council of 
Europe Convention for the Protection of 
Vertebl:afe Animals Used for Experimental 
and Other Scientific Plllposes (111 and 
COllllcil Directive 8616091EEC of 24 
November 1986 on the Approximation of 
Laws, Regulations and Administrative 
Provisions of the Member States Regarding 
the Protection of Animals Used for 
Experimental and Other ScientiJ;c Purposes 
1121. 
Meanwhile, the British Home Secretary, 
Merlyn Rees, said that he would consider lis-
tening to proposals for the reform of the 
1876 Act, but only if animal welfare organi. 
sations would agree on a policy among them-
selves. An alliance was therefore formed 
between CRAE, FRAME and the British 
Veterinary Association (BVA; 9). A set of 
BV NCRAE/FRAME proposals were submit-
ted in 1983 113), which greatly influenced 
British Government thinking, as revealed in 
two White Papers (14, 151. In what was a 
841 
very dramatic development at the time, the 
1985 White Paper contained a commitment 
to the Three Rs concept, in these words: 
"Animal experiments that are unnecessary, 
use unnecessarily large numbers of animals, 
or are unnecessarily painful, are indefensi-
ble." 
Members of the BV NCRAE/FRAME 
alliance were invited to act as advisers to the 
British Government during the preparation 
and passage through Parliament of the 
Animals (Scientific Procedures) Act 1986 
061, which was supported by both the 
Conservative and Labour parties and 
replaced the 1876 Act. The 1986 Act set up a 
project and personal licensing system, as well 
as an independent Animal Procedures 
Committee (APC), which can give advice to 
the Government, whether or not it is 
wanted. The Act contains two particularly 
important clauses (161: 
5141. In determining whether and on what 
terms to grant a project licence the Secretary 
of State shall weigh the likely adverse effects 
on the animals concerned against the benefit 
likely to accrue as a result of the programme 
of work to be specified in the licence. 
515 J. The Secretary of State shall not grant a 
project licence unless he is satisfied that the 
applicant has given adequate consideration 
to the feasibility of achieving the purpose of 
the programme to be specified in the licence 
by means not involving the use of protected 
animals. 
Directive 86/609/EEC 1121 spelled out its 
Three Rs basis in Article 7, as follows: 
7.2. An experiment shall not be performed if 
another scientifically satisfactory method of 
obtaining the result sought, not entailing the 
use of an animal, is reasonably and practica~ 
blyavailable. 
7.3. When an experiment has to be per-
formed, the choice of species shall be care-
fully considered and, where necessary, 
explained to the authority. In a choice 
between experiments, those which use the 
minimum number of animals, involve ani-
mals with the lowest degree of neurophysio-
logical sensitivity, cause the least pain, 
suffering, distress or lasting harm and which 
are most likely to provide satisfactory results 
shall be selected. 
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7.4. All experiments shall be designed to 
avoid distress and unnecessary pain and suf-
fering to the experimental animals. 
Similar words are used in the Council of 
Europe Convention (11), 
In Germany, when the national legislation 
on animal protection was changed in 1987 to 
meet the requirements of Directive 
86/609/EEC, a clause was inserted which 
requires the Federal Government to present 
a report (the Tierschzttzbericht) to the 
Bundestag every two years, to document the 
progress made with respect to the implemen-
tation of animal protection measures. This 
puts pressure on the relevant government 
institutions to take the necessary steps to 
implement current legislative requirements 
for animal protection. According to the 
German animal protection act (the 
Tierschutzgesetz), nobody is allowed to cause 
pain, suffering or harm to an animal without 
good reason. The legislation closely resem-
bles Direclive 86/609/EEC, with an addi-
tional provision which prohibits animal 
experimentation for developing tobacco 
products, washing detergents and decorative 
cosmetics. 
In The Netherlands, the Act on Animal 
Experimentation was adopted in 1977. Items 
included in this Act which are of importance 
with regard to the implementation of the 
Three Rs are: 
a) Mandatory registration of animal use. 
bl Prohibition of the use of an animal for a 
purpose that could be achieved equally by 
using in vitro methods or other non-ani~ 
mal procedures. 
c) The requirement that persons involved in 
animal experimentation are shown to be 
competent. Education and training in the 
field of laboratory animal science, includ~ 
ing ethics and alternatives, is mandatory 
for scientists and animal technicians. 
d) The requirement that institutions where 
animal experiments are conducted must 
be licensed. 
e) The requirement that a certificated ani-
mal welfare officer be appointed in asso-
ciation with the licence for the institute. 
D Mandatory use of anaesthetics and anal-
gesics when appreciable pain is antici-
pated. Their use may only be omitted 
when this would jeopardise the purpose 
of the experiment. 
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At present, the 1977 Act is being revised; the 
amended Act will include provisions relating 
to Animal Experimentation Committees 
(AECs; see section on Scientific and Ethical 
Justification). 
Following the adoption of the Act on 
Animal Experimentation, several initiatives 
were undertaken. A Department of 
Laboratory Animal Science was established 
at Utrecht University in 1983; in this 
Department, research and education pro-
grammes have been developed which are 
specifically directed toward further imple-
mentation of the Three Rs, and courses on 
laboratory animal science are routinely held 
for scientists. In 1987, the Dutch 
Alternatives to Animal Experiments 
Platform was established, through which 
government, industry and animal welfare 
organisations cooperate in order to stimulate 
the development and use of alternative 
methods. The main task of the Platform is to 
advise the Government on the funding of 
research projects concerned with the devel-
opment of alternatives. The Netherlands 
Centre Alternatives to Animal Use (NCA) 
was established in Utrecht in 1994, as a 
national information centre on alternatives. 
The main objective of the NCA is to stimu-
late the development, validation, acceptance 
and use of alternative methods; that is, the 
NCA supports the Platform in seeking to 
realise its goal. 
In the USA, the Johns Hopkins Center for 
Alternatives to Animal Testing (CAAT) was 
founded in 1981, with the support of a grant 
from the Cosmetic, Toiletry and Fragrance 
Association, to address the major issues fac-
ing the development of alternatives (17). 
CAAT's initial focus was on establishing a 
small grants programme, through which it 
has funded the development of new in vitro 
systems, and of assays that could ultimately 
be used for product safety testing, by funda-
mental research scientists. Over the years, 
CAA T has become a visible advocate of the 
Three Rs, and it fulfils a unique role in the 
USA in liaising with scientists from acade-
mia, industry and governmental organisa-
tions. In this capacity, CAAT has organised 
regular scientific symposia and has played a 
major role in bringing together diverse 
groups to formulate a framework for the val-
idation of alternative methods for product 
safety testing (18). 
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During the early 1980s, the campaigns 
against the Draize and LD50 tests, and 
simultaneous attempts to pass legislation in 
the USA to promote the use of alternatives, 
focused industrial and congressional atten-
tion on alternative methods. Public pressure 
led to the revision and strengthening of the 
US Animal Welfal'e Act and the Public 
Health Service Policy on the Humane Care 
and Use of Labol'ato;y Animals (191, both of 
which incorporated the requirement that 
consideration be given to the Three Rs 
before any research involving the use of ani-
mals was started. The concept of alternatives 
was also promoted via legislation relating to 
the role and activities of the National 
Institutes of Health (NIH), 
In 1986, a report by the US Congress 
Office of Technology Assessment on 
Alternatives to Animal Use in Research, 
Testing a.nd Educa.tion (20) provided evi-
dence of the broad scope and potential of the 
Three Rs concept of alternatives and, in the 
same year, the Health Research Extension 
Act gave legislative force to the revised 
Public Health Service Policy on animal 
research. In Europe, the European Research 
Group for Alternatives in Toxicity Testing 
(ERGATT) was also established in 1986. 
A set of International Guiding Principles 
for Biomedical Research Involving Animals 
were published in 1985 (21); the basic princi-
ples are outlined in Table 1. Thus, by the end 
of the 1980s, new laws were in place in vari· 
ous parts of the world, which not only recog-
nised Russell and Burch's concept, but 
placed legal and moral obligations on all con-
cerned to seek to replace, reduce andlor 
refine laboratory animal experimentation 
wherever possible. Full implementation of 
these laws and the development of replace· 
ment alternatives became the next chal· 
lenges. 
In 1993, the US NIH Revitalization Act 
included statements drafted and supported 
by animal protection organisations and by 
several large corporations which promote the 
concept of alternatives. In particular, the Act 
authorised the establishment of an Applied 
Toxicology Program within the National 
Institute of Environmental Health Sciences 
(NIEHS), which eventually developed into the 
Interagency Coordinating Committee for the 
Validation of Alternative Methods (ICCVAM). 
At the same time, a group of scientists 
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Table I: International Guiding Principles for Biomedical Research Involving 
Animals 
1. The advancement of biological knowledge and the development of improved means for 
the protection of the health and well-being both of man and of animals require recourse 
to experimentation on intact live animals of a wide variety of species. 
II. Methods such as mathematical models, computer simulation and in vitro biological sys-
tems should be used wherever appropriate. 
III. Animal experiments should be undertaken only after due consideration of their rele-
vance for human or animal health and the advancement of biological knowledge. 
IV. The animals selected for an experiment should be of an appropriate species and quality, 
and the minimum number required, to obtain scientifically valid results. 
V. Investigators and other personnel should never fail to treat animals as sentient, and 
should regard their proper care and use and the avoidance or minimisation of discom-
fort, distress, or pain as ethical imperatives. 
VI. Investigators should assume that procedures that would cause pain in human beings 
cause pain in other vertebrate species although more needs to be known about the per-
ception of pain in animals. 
VII. Procedures with animals that may cause more than momentary or minimal pain or dis-
tress should be performed with appropriate sedation, analgesia or anaesthesia in accor-
dance with accepted veterinary practice. Surgical or other painful procedures should not 
be performed on unanaesthetised animals paralysed by chemical agents. 
VIII. Where waivers are required in relation to the provisions of article VII, the decisions 
should not rest solely with the investigators directly concerned but should be made, with 
due regard to the provisions of articles IV, V and VI, by a suitably constituted review 
body. Such waivers should not be made solely for the purpose of teaching or demon-
stration. 
IX. At the end of, or when appropriate during, an experiment, animals that would otherwise 
suffer severe or chronic pain, distress, discomfort, or disablement that cannot be 
relieved should be painlessly killed. 
X. The best possible living conditions should be maintained for animals kept for biomed-
~ ical purposes. Normally the care of animals should be under the supervision of veteri-
narians having experience in laboratory animal science. In any case, veterinary care 
should be available as required. 
XI. It is the responsibility of the director of an institute or department using animals to 
ensure that investigators and personnel have appropriate qualifications or experience 
for conducting procedures on animals. Adequate opportunities shall be provided for in-
service training, including the proper and humane concern for the animals under their 
care. 
Taken from Howard-Jones, (21). 
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from key regulatory agencies in the USA 
established the Interagency Regulatory 
Alternatives Group (IRAG; an ad hoc com-
mittee), to discuss the implementation of 
alternatives in the regulatory sector. 
In 1989, Alan Goldberg and Bert van 
Zutphen decided to initiate a series of world 
congresses devoted to alternatives and ani-
mal use in the life sciences (covering the 
Three Rs in research, testing and education), 
which were to be held every three years. The 
first World Congress was held in Baltimore, 
USA, in November 1993, and was attended 
by 725 people (representing academia, indus-
try, and government and animal protection 
organisations) from 24 countries (22). The 
second World Congress is to be held in 
October 1996 in Utrecht, in The 
Netherlands, while a third World Congress, 
to be held in Italy in 1999, is already being 
planned. 
It is clear that significant changes have 
occurred in the planning and conduct of bio-
medical research projects. In Great Britain, 
where reasonably accurate statistics on ani-
mal use are available, the data indicate that 
the use of animals increased by an average of 
6% per year between 1937 and 1971, to a 
total of over 5.5 million (23). From 1972 to 
1978, the number of animals used remained 
relatively stable, and then animal use began 
to decrease by an average of 5% per year 
from 1979 onwards. The increase in animal 
use was driven largely by the search for new 
drugs and the expansion of the pharmaceuti-
cal industry. Since the mid-1970s, the use of 
animals in commercial, government and uni-
versity/hospital laboratories in Britain has 
dropped by 65%, 56% and 26%, respectively. 
In The Netherlands, total animal use has 
declined by 50% since 1978 (24). While the 
data for the USA are less reliable, it has been 
argued that animal use has also decreased 
significantly in American laboratories, 
despite funding for biomedical research hav-
ing increased during this period (25). 
In the mid-1990s, the question we face is 
whether there will be a revolution in think-
ing and practice, which is what is needed if 
the expectations of Hume, Russell, Burch, 
Lane-Petter, Medawar, Stevens, and all the 
others involved in the original UFAW pro-
ject, are to be met, and the principles of 
humane experimental technique are to be 
brought fully and effectively into operation. 
Much has been achieved, but there is still 
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considerable room for progress and improve-
ment. 
Scientific and Ethical Justification 
All proposed use of laboratory animals 
should be subject to review, to determine 
whether such use appears to be scientifically 
and ethically justifiable. In some circum-
stances, the "alternative" may simply be not 
to undertake the animal procedure at alL 
Where the necessity of conducting certain 
animal procedures cannot be justified suffi-
ciently on scientific or ethical grounds, the 
project proposal should be rejected. 
Guidelines have been prepared to assist 
review committees in assessing whether 
alternatives have been adequately consid-
ered (26). 
In their consideration of the ethics of 
using animals in biomedical research, a 
Working Party of the Institute of Medical 
Ethics (UK) concluded that "a research pro-
ject involving animal subjects should take 
place only when it can be shown: 
a) that the aim of the project is worthwhile; 
b) that the design of the project is such that 
there is the strong possibility that it will 
achieve the aim; 
c) that the aim could not be achieved using 
morally more-acceptable and scientifi-
cally no less-acceptable alternative sub-
jects and procedures; and 
dl that the likely benefits of the project are 
substantial enough in relation to the suf-
fering likely to be caused to the animals 
used (that is, the likely benefits of the 
research should be 'weighed' against the 
'costs' to the animals involved)"(27). 
It is these four main points, which include 
the need to consider the potential for using 
alternative methods, which should be 
addressed to the satisfaction of the reviewers 
(who generally include biomedical scientists, 
veterinarians, ethicists, and community rep-
resentatives with an interest in animal pro-
tection). 
The UK system involves licensing specific 
persons both with respect to the projects to 
be undertaken and for their personal use of 
laboratory animals (28). It provides a com-
prehensive and vigorous system of controls 
when taken together with the formal certifi· 
cation (designation) of heads of establish-
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ments where experimental animals are used 
and the common species are bred. The 
Animals (Scientific Procedures) Act 1986 also 
provides for the appointment of inspectors in 
the Home Office (the government departM 
ment equivalent to the ministry of internal 
affairs in other countries). Home Office 
Inspectors check all designated establish-
ments to ensure compliance with, or to 
report on non-compliance with, the 1986 Act, 
or with the terms and conditions of licences 
or certificates issued under the Act. 
Uniquely in Britain, individual Home 
Office Inspectors statutorily review projects 
and protocols, and advise the Minister (in 
practice, his officials) on the costs versus 
benefits, with the aim of ensuring that only 
properly justified work is licensed; these are 
functions performed by ethics review com-
mittees in other countries. Where appropri-
ate, views on proposed research projects are 
sought from other Inspectors and, occasion-
ally, from external assessors or the APC. 
Some special categories of work are manda-
torily referred to the APC, for example, work 
with primates and on cosmetics, and applica-
tions to use animals for microsurgical train-
ing. Home Office Inspectors only make 
recommendations to government officials 
but, in practice, their advice is usually 
accepted. Inspectors have almost no formal 
enforcement or executive powers with regard 
to licensees, but can order the immediate 
humane killing of animals they consider to 
be suffering excessively. Experimenters 
rarely disregard the views of Home Office 
Inspectors on the extent to which practical 
outcomes match the detailed protocols 
authorised by project licences. 
In Germany, the Department of 
Agriculture, which is responsible for animal 
protection, adopts the general philosophy 
that, even if it is more expensive to use a 
non-animal method than to conduct an ani-
mal procedure, a lower cost is not sufficient 
justification for using animals. However, in 
1994, the highest constitutional court in 
Germany ruled that an animal experiment 
which is scientifically justifiable cannot be 
prohibited for ethical reasons, interpreting 
this to be in compliance with both the 
national legislation and Directive 
86/609/EEC. 
In The Netherlands, the performance of 
animal experiments is not permitted unless 
the protocol has been reviewed and approved 
by an AEC. According to the proposed revi-
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sion of the 1977 Act on Animal 
Experimentation, the chairperson and at 
least two other members of such a committee 
must be independent (that is, they must not 
have a working relationship with the institu-
tions for which the protocol is reviewed). 
Furthermore, the AEC must also include 
experts on ethics and on alternative meth-
ods, and the composition of the committee 
must be approved by the National 
Committee on Animal Experimentation. The 
main tasks of an AEC are to evaluate 
whether the expected benefit of the proposed 
experiment outweighs the likely suffering of 
the animals concerned. and to ascertain that 
the feasibility for implementing the Three Rs 
has been adequately taken into account 
when preparing the protocol. AECs are also 
required to evaluate the competence of the 
persons involved in the design and perfor-
mance of the experiments. Rejection of a pro-
posed research protocol by the AEC can only 
be overruled by the National Committee on 
Animal Experimentation. 
In the USA, under both the Animal 
Welfare Act amendments of 1985 (regula-
tions approved in 1989) and the Public 
Health Service revised policy, Institutional 
Animal Care and Use Committees ([ACUCs) 
are required to review and approve all ani-
mal research proposals before the research is 
allowed to proCeed. The IACUCs are 
expected to ensure that approved animal 
research protocols are worthwhile, that they 
use the minimum number of animals neces-
sary, that animal pain and distress are min-
imised, and that, in any procedures likely to 
cause animal pain and distress (whether or 
not anaesthetics or analgesics are used). 
principal investigators document that they 
have established "that alternatives were ade-
quately considered"(29). 
While the manner in which IACUCs pur-
sue their duties varies, the inspectors enforc-
ing the Act have paid particular attention to 
the requirement that investigators docu-
ment the lack of alternatives, and to the sec-
tion of the regulations which reads: 
"Research facilities will be held responsible if 
it is subsequently determined that an alter-
native procedure was available to accomplish 
the objectives of the proposed experiment ... 
or if it is subsequently determined that an 
experiment is unnecessarily duplicative and 
that a good-faith review of available sources 
would have indicated as much." 
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As a result, the consideration of alternatives 
in the USA, while not necessarily embraced 
enthusiastically, is becoming routine during 
the preparation of research proposals. 
Selection of Appropriate Animals 
In whatever country the research is to be 
conducted, in designing a project the investi-
gator should first consider whether the aims 
of the project could be realised by using in 
vitro techniques or less sentient animal 
species, such as insects or nematodes. The 
replacement of one animal species with 
another, particularly if the species which is 
then used is non-vertebrate, could also be 
considered to be an alternative method (30). 
Therefore, the model selected should be the 
lowest phylogenetic species, and also the 
least sentient species, which will allow the 
scientific objectives to be realised. If the use 
of living vertebrates is considered to be 
essential, the aim should be to use the mini-
mum possible number of animals (see the 
section on Reduction Alternatives), and to 
use strategies which will ensure that the ani-
mals which must be used are subject to the 
minimum discomfort (see the section on 
Refinement Alternatives). 
A variety of strains of certain species are 
available. For example, over 400 inbred 
strains of mice and over 200 inbred strains of 
rats have been developed. These provide a 
wide range of phenotypes which are of pot en-
tial value in many areas of research. The 
choice of strain for a particular project 
should largely be governed by a knowledge of 
its characteristics, and by the need to control 
phenotypic variability. In most cases, iso-
genic (inbred or Fl hybrid) animals are more 
suitable than outbred stocks, because of 
their high phenotypic uniformity, long-term 
stability, identifiability, and detailed back-
ground information on their characteristics 
(31). 
However, in biological assays against stan-
dards (where phenotypic uniformity is espe-
cially important), although Fl hybrids are 
usually more uniform than inhreds, there 
are no a priori grounds for choosing the most 
suitable strain or cross for a particular assay, 
and further studies of the type described by 
Hendriksen et al. (32) should be undertaken, 
preferably as part of ongoing studies to min-
imise the number of animals which are used 
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for each assay and the degree of discomfort 
caused by current assay procedures. 
Where uniformity is important, it can also 
be promoted by controlling the environment 
in which the animals are reared and used. As 
Chance discovered many years ago (reviewed 
in Russell & Burch 1211, this does not mean 
keeping the environment uniform and con-
stant in all respects, but rather keeping it 
uniform, constant and appropriate in certain 
key respects. Reduction here generally coin-
cides with the concept of refinement. For 
example, as described by Fox (33), "handling 
weanling female rats for three days prior to 
experiments using the Steelman-Pohley 
method of follicle-stimulating hormone assay 
reduced the variability of their response", so 
that "about twice as many non-handled rats 
would be required in an assay to obtain the 
same degree of precision as with handled 
rats". 
Reduction Alternatives 
The term reduction alternatives describes 
methods for obtaining comparable levels of 
information from the use of fewer animals in 
scientific procedures, or for obtaining more 
information from a given number of animals, 
so that, in the long run, fewer animals are 
needed to complete a given research project 
or test. 
The greater the number of animals used in 
an experiment, the greater will be the overall 
costs, in terms of animal suffering (27l. 
Thus, the number of animals used should be 
the minimum which is consistent with the 
aims of the experiment. However, past expe-
rience in the area of regulatory toxicity test-
ing, for example, suggests that laboratory 
animal welfare considerations and common 
sense do not always prevail (for example, in 
LD50 testing; 341. Saving of time or personal 
convenience, or other non-scientific reasons, 
are not sufficient justification for using more 
animals than the minimum necessary to 
obtain meaningful results. Proper statistical 
design, prior to undertaking the study, and 
appropriate analysis of the resulting data, 
may make it possible to obtain .results of 
comparable precision by using fewer ani-
mals. 
The precision of an experiment depends 
mainly on the sample size and the "error" 
variance and not on the body weight of the 
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test animal. The use of more animals on the 
grounds that they are smaller and less 
expensive is not scientifically justifiable. If a 
test has to be conducted in a rodent and in a 
non-rodent species and the test guideline 
specifies the use of four dogs, then the use of 
more than four rats cannot be scientifically 
justifiable. It is recognised that problems 
with a protocol may be encountered once the 
experiment is under way. To prevent the 
continuation of unsuccessful animal experi-
ments without review, acceptable limits for 
failures in protocols, and the actions to be 
taken if these occur. should be specified. 
Careful attention should also be given to 
the type of endpoint to be used. Qualitative 
endpoints (for example, dead/alive) often 
involve severe animal pain and distress, and 
generally provide less information than do 
quantitative measurements. 
Research strategy 
Relatively little consideration has been given 
to research strategy f';ince Russell and Burch 
(2) discussed the random screening ofpoten~ 
tial new pharmaceutical agents under this 
heading. Such screening is now largely done 
by using in vitro systems, which is one rea-
son for the decrease in the numbers of ani-
mals used in the last decade. However, 
research strategy is also important in other 
contexts. In particular, it may be necessary 
to carry out small pilot studies which can be 
reviewed before committing animals and 
resources to major experiments. The statisti-
cal guidelines developed by Muller et ai. (35), 
which include a detailed discussion of possi-
ble research strategies, should be brought to 
the attention of biomedical investigators. 
Experimental design and statistics 
Optimum experimental design and statisti-
caL considerations may suggest that a partic-
ular protocol employs an insufficient number 
of animals, and that more are needed to pro-
vide a satisfactory answer to the question 
being posed. However, this should still lead 
to an overall reduction in animal use, since 
experiments which use too few animals will 
generally not achieve their desired objec-
tives, and will frequently need to be repeated 
with a larger number of animals. 
Regulatory tests 
International harmonisation of protocols in 
regulatory testing should lead to an overall 
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reduction in the use of animals, provided 
that there is a reasonable compromise on 
acceptable sample sizes. Such harmonisation 
should provide an opportunity to review the 
design and sample sizes required in regula-
tory experiments, since, in some cases, sam-
ple sizes appear to have been decided in an 
arbitrary manner, without taking statistical 
considerations into account. Where possible, 
the requirements should be formulated in 
terms of acceptable confidence intervals, 
rather than by specifying the numbers of 
animals needed, so that where greater con-
trol of phenotypic variation is possible, the 
number of animals can be reduced. 
Efforts at international harmonisation 
should target not only the protocols for par-
tinliar tests, but also the specific require-
ments for those tests. This would reduce the 
numbers of animals used by minimising the 
array of tests required. 
Non-regulatory experiments 
There is evidence that poor experimental 
design and inappropriate statistical analysis 
of experimental results is leading to ineffi-
cient use of animals and of scientific 
resources in toxicological research (36-38). 
This is in agreement with previous studies of 
statistical methods used in other areas of 
biomedical research (37-41). However, more 
investigation is needed to determine whether 
appropriate experimental design and statisti-
cal analysis are employed in other areas of 
research, such as experimental surgery, 
pharmacology, biochemistry, experimental 
immunology, and microbiology. 
In some cases, the level of statistical 
expertise appears to be so low that investiga-
tors are either unaware of the potential 
value of obtaining statistical advice, or they 
are unable to obtain appropriate statistical 
advice, because there are so few biometri-
cians with experience in their field of inter-
est. 
The "named statisticia.n" 
In some countries, a "named veterinarian" 
must be appointed to supervise some aspects 
of laboratory animal welfare. In view of the 
importance of good experimental design and 
appropriate statistical analysis in underpin-
ning high quality research, and the potential 
savings in terms of the numbers of animals 
which are used, consideration should be 
given to the need for a full-time or part-time 
"named statistician" to be associated with 
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research facilities. This statistician would 
undertake to be available to all investigators 
who needed advice on experimental design 
and statistical analysis of experimental data, 
and possibly would have some statutory 
obligation to' meet regularly with investiga-
tors to discuss current research projects. 
Education in statistics 
A basic understanding of experimental 
design and statistics is necessary for all sci-
entists. For investigators with no previous 
training in statistics, this level of expertise 
can probably be obtained from a course 
involving the equivalent of about 30 hours of 
lectures and associated practical work. 
However, an equivalent level of expertise 
could also be obtained by reading and by 
using computer-assisted learning tech-
niques. Books by Cox (42) and Cochran & 
Cox (43) provide a good introduction to 
experimental design; Cohen (44) deals specif-
ically and in detail with the problem of deter-
mining the appropriate size for an 
experiment. There are many texts on statis-
tical methods, which can be used both for 
learning purposes and as reference books 
(45-48). There is also a need for some bio-
medical research workers to have a more 
detailed training in biometrics/statistics, so 
that they can act as consultants to other 
investigators in their own institutes. 
Refinement Alternatives 
Refinement alternatives encompass those 
methods which alleviate or minimise poten: 
tial pain and distress, and which enhance 
animal well-being. "Distress" is an aversive 
state in which an animal is unable to adapt 
completely to stressors and the resulting 
stress, and therefore shows maladaptive 
behaviour (49), The stressors may induce 
physiological, psychological or environmen-
tal stress. "Pain" results from potential or 
actual tissue damage, such as that caused by 
injury, surgery or disease, and can lead to 
distress. These terms and concepts have 
been defined and discussed previously 
(49-51). 
Pain and distress can result from both 
experimental and non-experimental causes. 
Potential sources of experimental pain and 
distress include: improper or prolonged 
restraint, experimental infections, chemical-
induced toxic effects, surgical and experi-
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mental procedures, post-operative pain, and 
improper euthanasia techniques. Non-expE>r-
imental sources include: naturally occurring 
infectious and non-infectious diseases. suh-
optimal environmental conditions, improper 
handling, stressful housing situations (for 
example, social isolation, barren cages or 
pens), injuries sustained during fighting. and 
injuries associated with the housing or 
caging. 
Much potential pain and distress can be 
avoided or at least alleviated with the proper 
use of anaesthetics, analgesics and tran-
quilisers, which is a critical component of 
any comprehensive programme of adequate 
veterinary care. Such a programme provides 
for frequent observation of the animals by 
trained veterinary staff, to detect and appro-
priately relieve pain and distress. However, a 
substantial number of animals used in 
research and testing experience unrelieved 
pain or distress. All experimental protocols 
should be sufficiently detailed with regard to 
the type and severity of likely adverse 
effects, the times of peak occurrence, 
humane endpoints, and the remedial actions 
to be taken. 
In The Netherlands, a serious attempt has 
been made to categorise animal experiments 
on the basis of the severity of pain and dis-
tress experienced. In 1993, 51.47< of the ani-
mals were reported to have experienced 
either no or minor discomfort, 26. Fk experi-
enced moderate discomfort, and 22.51}(· expe-
rienced severe discomfort (with a fifth of 
these receiving drugs to prevent or relieve 
the pain or distress; 24), 
The percentage of animals experiencing 
unrelieved pain and distress from non-exper-
imental causes is not known. Recent 
advances in science and technology, and in 
laboratory animal medicine, offer significant 
opportunities to develop alternative methods 
which may further reduce or eliminate unre-
lieved pain and distress. It is proposed that 
research, testing and education facilities are 
encouraged to improve and optimise the 
well-being of laboratory animals, for exam-
ple, by: 
a) The procurement and maintenance of 
animals free of pathogenic organisms; 
this requires effective vendor surveil-
lance, quarantine, health monitoring, 
disease investigation and preventive 
medicine programmes. 
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b) The provision of optimal caging and hus-
bandry procedures (appropriate to the 
physiological and behavioural needs of 
the species), such as avoiding caging ani-
mals singly whenever feasible and practi-
cal. 
c) The provision of optimal environmental 
conditions, with minimal variations in 
temperature, humidity, etc. 
d) The provision of enrichment/exercise 
programmes where they are appropriate 
and will be beneficial. 
Need for a.ssessment measures of animal pain 
and distress 
At present, we do not have a convenient and 
standardised way of objectively assessing 
animal pain and distress. Rather, the assess-
ment is generally based on subjective clinical 
signs of abnormal behaviour and appearM 
ance. The approach to animal pain and dis-
tress is to assume that a procedure which 
inflicts pain and distress in human beings 
will inflict at least as much pain and distress 
in animals, unless there is evidence to the 
contrary (52, 53). 
There are wide variations among different 
countries with respect to assessments of the 
extent of pain and distress caused by particM 
ular husbandry and experimental 
approaches. There are no internationally 
defined standards on animal pain and disM 
tress or agreed cut-off points, although some 
working guidelines have been produced and 
disseminated widely (for example, 54). There 
are a number of specific national guidelines 
on procedures which cause particular con-
cern, such as those on cancer research proM 
duced by the UK Coordinating Committee on 
Cancer Research (55), on antibody produc-
tion (56), and on lethal endpoint screening 
tests for antimicrobial agents (57). The num-
ber of techniques or scientific procedures 
that are commonly used and are of signifiM 
cance probably amount to no more than one 
or two hundred. 
Before adverse effects on animals can be 
assessed, one must be able to recognise such. 
effects via either behavioural or physiological 
measures. Several such measures have been 
suggested (for example, 58-60), but have not 
been widely adopted. In order to prioritise 
which husbandry and experimental proce-
dures need to be refined and modified, appro-
priate objective measures of adverse effects 
on animals need to be developed, validated 
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and aggressively disseminated (52). 
International harmonisation 
Attitudes differ as to which scientific proce-
dures lead to animal pain and distress, and 
the severity of the pain and distress they 
cause. Efforts to identify these differences, to 
determine the underlying reasons for them, 
and to harmonise international standards as 
much as possible should be undertaken. 
Research support for refinement alternatives 
Very little research funding is available to 
support efforts to investigate and refine 
experimental techniques and scientific pro-
cedures. Some ad hoc funding has supported 
workshops on antibody production, adjuvant 
use and infectious disease models. The BVA 
Animal Welfare Foundation, FRAME, the 
RSPCA and UFAW formed a Joint Working 
Group on Refinement in 1989, with the 
intention of setting up a series of workshops 
to discuss ways in which common laboratory 
procedures could be refined. The first and 
second reports were on the removal of blood 
from laboratory mammals and birds (61) and 
on refinements in rabbit husbandry (62), 
respectively. Nevertheless, no sustained 
source of funding is available to support the 
relatively modest research projects which 
could provide th~ impetus to develop an 
appropriate measure 9f adverse effects on 
animals, and which could provide essential 
data on the actual impact of particular scien-
tific procedures and experimental tech-
niques. Some research funding is available to 
support animal husbandry modifications and 
environmental enrichment (especially for 
primates, dogs and cats), but there is little 
funding available to explore environmental 
enrichment in rodent housing, despite the 
fact that rodents constitute 85% of all labo-
ratory animals used in experiments. 
Dissemination of information on refinement 
alternatives 
Scientists are not sufficiently aware of the 
concept of refinement alternatives and, in 
general, they do not recognise the impor-
tance of refinement in their research. The 
concept of recognising, minimising and elim-
inating pain and distress in laboratory ani-
mals should be included in training 
programmes for all persons involved in the 
care and use oflaboratory animals. Details of 
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research facilities. This statistician would 
undertake to be available to all investigators 
who needed advice on experimental design 
and statistical analysis of experimental data, 
and possibly would have some statutory 
obligation to· meet regularly with investiga-
tors to discuss current research projects. 
Education in statistics 
A basic understanding of experimental 
design and statistics is necessary for all sci-
entists. For investigators with no previous 
training in statistics, this level of expertise 
can probably be obtained from a course 
involving the equivalent of about 30 hours of 
lectures and associated practical work. 
However, an equivalent level of expertise 
could also be obtained by reading and by 
using computer-assisted learning tech-
niques. Books by Cox (42) and Cochran & 
Cox (43) provide a good introduction to 
experimental design; Cohen (44) deals specif-
ically and in detail with the problem of deter-
mining the appropriate size for an 
experiment. There are many texts on statis-
tical methods, which can be used both for 
learning purposes and as reference books 
(45-48). There is also a need for some bio-
medical research workers to have a more 
detailed training in biometrics/statistics, so 
that they can act as consultants to other 
investigators in their own institutes. 
Refinement Alternatives 
Refinement alternatives encompass those 
methods which alleviate or minimise poten: 
tial pain and distress, and which enhance 
animal well-being. "Distress" is an aversive 
state in which an animal is unable to adapt 
completely to stressors and the resulting 
stress, and therefore shows maladaptive 
behaviour (49). The stressors may induce 
physiological, psychological or environmen-
tal stress. "Pain" results from potential or 
actual tissue damage, such as that caused by 
injury, surgery or disease, and can lead to 
distress. These terms and concepts have 
been defined and discussed previously 
(49-51). 
Pain and distress can result from both 
experimental and non-experimental causes. 
Potential sources of experimental pain and 
distress include: improper or prolonged 
restraint, experimental infections, chemical-
induced toxic effects, surgical and experi-
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mental procedures, post-operative pain. and 
improper euthanasia techniques. Non-exper-
imental sources include: naturally occurring 
infectious and non-infectious diseases. suh-
optimal environmental conditions, improper 
handling, stressful housing situations (for 
example, social isolation. barren cages or 
pens), injuries sustained during fighting. and 
injuries. associated with the housing or 
caging. 
Much potential pain and distress can be 
avoided or at least alleviated with the proper 
use of anaesthetics, analgesics and tran-
quilisers, which is a critical component of 
any comprehensive programme of adequate 
veterinary care. Such a programme provides 
for frequent observation of the animals by 
trained veterinary staff, to detect and appro-
priately relieve pain and distress. However, a 
substantial number of animals used in 
research and testing experience unrelieved 
pain or distress. All experimental protocols 
should be sufficiently detailed with regard to 
the type and severity of likely adverse 
effects, the times of peak occurrence, 
humane endpoints, and the remedial actions 
to be taken. 
In The Netherlands, a serious attempt has 
been made to categorise animal experiments 
on the basis of the severity of pain and dis-
tress experienced. In 1993, 51.4'7r of the ani-
mals were reported to have experienced 
either no or minor discomfort. 26.1(Yr- experi-
enced moderate discomfort. and 22.50'r· expe-
rienced severe discomfort (with a fifth of 
these receiving drugs to prevent or relieve 
the pain or distress; 24), 
The percentage of animals experiencing 
unrelieved pain and distress from non-exper-
imental causes is not known. Recent 
advances in science and technology, and in 
laboratory animal medicine, offer significant 
opportunities to develop alternative methods 
which may further reduce or eliminate unre-
lieved pain and distress. It is proposed that 
research, testing and education facilities are 
encouraged to improve and optimise the 
well-being of laboratory animals, for exam-
ple, by: 
a) The procurement and maintenance of 
animals free of pathogenic organisms; 
this requires effective vendor surveil-
lance, quarantine, health monitoring, 
disease investigation and preventive 
medicine programmes. 
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refinement and animal welfare considera-
tions should routinely be included in scien-
tific papers and publications (63). 
Refinement alternatives have multiple bene-
fits, and the promotion of their implementa-
tion should include the publication of 
appropriate review articles which document 
the scientific, economic and humane bene-
fits. 
There is no readily available up-to-date 
knowledge base on refinement. Techniques 
that are developed to refine a procedure are 
frequently not reported in the scientific liter-
ature, or are established simply as Standard 
Operating Procedures (SOPs) within an 
institution. To establish "best practice"and 
to advance the implementation of refinement 
alternatives, it is important to share such 
experience, data and SOPs. Sharing of data 
and theories is normally accomplished via 
the scientific literature, but there has been a 
marked lack of opportunity to discuss and 
provide information on refinement alterna-
tives in the main biological journals. 
Since the pioneering work of Chance (64), 
there have been several publications on the 
assessment of distress and refinement proce-
dures (2, 33), which should be made as 
widely known as possible (65-67). In particu-
lar, experimenters should be familiar with 
the important general survey by Claassen 
(68). As pointed out by Gardner & Gardner 
(69), acceptance of the very real need for 
more research in distress assessment and 
refinement should not discourage us from 
,making urgently needed immediate improve-
ments in cases where there are obvious phys-
iological or behavioural indications of stress, 
and therefore of distress, due to factors such 
as overcrowding, social isolation or restraint. 
Auditing system 
Auditing of the implementation of refine-
ment alternatives at the institutional level is 
rarely carried out, although it can easily be 
done by requiring investigators to provide 
basic information for review by ethics com-
mittees/IACUCs, or by independent review 
by animal welfare officers, laboratory animal 
veterinarians, or government inspectors. 
Such data can significant.ly enhance the 
development of further refinements, and 
raise awareness of the concept of refinement 
and its importance. 
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Replacement Alternatives 
Replacement alternatives encompass those 
methods which permit a given purpose to be 
achieved without conducting experiments or 
other scientific procedures on animals. 
Russell & Burch (2) distinguished between 
relative replacement, for example, the 
humane killing of a vertebrate animal to pro-
vide cells, tissues and/or organs for in vitro 
studies, and absolute replacement, in which 
animals would not need to be used at all, for 
example, the culture of human and inverte-
brate cells and tissues. 
It was discussed whether animal organ-
atypic and primary cell culture should be 
classed as reduction, since an animal would 
still have to be used, whereas serial cell cul-
ture, for example, the use of permanent cell 
lines, would be classed as replacement. It 
was thought to be preferable to continue to 
use Russell and Burch's approach, partly 
because the use of different terms for non-
human vertebrate primary cultures on the 
one hand, and human and invertebrate pri-
mary cultures and non-human vertebrate 
serial cell cultures on the other, would lead 
to confusion, and partly because the humane 
killing of an animal does not represent an 
experiment or a regulated scientific proce-
dure in most countries. 
Nevertheless, statistics on ~nimal use 
should include the numbers of animals killed 
specifically for the purpose of providing cells 
and tissues for in vitro studies, and for the 
production of subcellular fractions, such as 
liver S9 preparations for use in metabolism 
and mutagenicity studies. Account should 
also be taken of the culling of animals sur-
plus to requirements, which can be very high 
in the breeding and supply of rodents. 
Replacement alternative methods and 
approaches 
The range of replacement alternative meth-
ods and approaches includes the following 
(27, 70, 71): 
a) The improved storage, exchange and use 
of information about animal experiments 
already carried out, so that unnecessary 
repetition of animal procedures can be 
avoided. 
bl The use of physical and chemical tech-
niques, and of predictions based on the 
physical and chemical properties of mole-
cules. 
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c) The use of mathematical and computer 
models, including: i) modelling of quantita-
tive structure-activity relationships, i.e. 
taking advantage of correlations between 
molecular structure and biological activity 
in the prediction of the potential desired 
and undesired effects of series of related 
chemicals; ii) molecular modelling and the 
use of computer graphics, for example in 
actively designing drugs and other chemi-
cals for specific purposes; and iii) modelling 
of biochemical, physiological, pharmaco-
logical, toxicological and behavioural sys-
tems and processes. 
d) The use of "lower" organisms with limited 
sentience and/or not protected by legisla-
tion controlling animal experiments, 
including invertebrates, . plants and 
microorganisms; for example, the use of 
bacteria in genotoxicity testing. 
e) The use of the early developmental stages 
of vertebrates before they reach the point 
at which their use in experiments and 
other scientific procedures is regulated. 
D The use of in vitro methods, including sub-
cellular fractions, short-term maintenance 
of tissue slices, cell suspensions and per-
fused organs, and tissue culture proper 
(cell and organotypic culture), including 
human tissue culture. 
g) Human studies, including the use of 
human volunteers, post-marketing surveil-
lance and epidemiology; for example, sldn 
patch testing in humans before marketing, 
and monitoring consumer response after 
marketing, as alternatives to the animal 
testing of cosmetic products. 
In many areas of the biomedical sciences, in 
vitro methods are increasingly used as the 
methods of choice in place of animal studies, 
not because they provide precisely the same 
information, but because they offer the best 
scientific approach to tackling the questions 
being asked. An example of this would be the 
use of tissue, cell and subcellular preparations 
in vitro for screening candidate compounds for 
pharmacological activity. The information pro-
vided by the in vitro methods may ultimately 
have an outcome similar to that provided by 
the animal studies used in the past (for exam-
ple, the identification oflead compounds). 
Replacement alternatives in research and 
testing 
A distinction also needs to be made between 
the replacement of animal use in fundamen-
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tal biomedical research and in regulatory 
testing (72), In the former case, scientific 
methodology evolves mainly through an 
informal publication and peer-review accep-
tance and/or improvement process. In the 
latter case, however, formal validation of the 
replacement alternative method in terms of 
its relevance and reliability for its stated pur-
pose is likely to be necessary (18, 73), since 
national or international laws, guidelines or 
regulations will need to be modified, if the 
non-animal test is to gain wide acceptance as 
a replacement for the animal test. In addi-
tion, as practised at present, regulatory test-
ing often requires the induction of adverse 
effects, and even of considerable animal suf-
fering, which are integral to the test proce-
dure and are therefore unavoidable. 
It follows from this that those of us who 
are concerned that the Three Rs concept 
should be implemented as fully as possible, 
should welcome the trend toward the use of 
non-animal methods in fundamental 
research. However, in the case of regulatory 
efficacy and toxicity testing, research specifi-
cally aimed at providing validated replace-
ments for the currently accepted animal test 
procedures and testing strategies should be 
conducted, and the value of such research 
should be recognised by the scientific com-
munity at large. This would be fully consis-
tent with one of the hopes expressed by 
Russell and Burch in the conclusion to their 
book, i.e. that their efforts "would stimulate 
some experimentalists to devote special 
attention to the subject"(2). 
A great deal of effort is being put into the 
development and evaluation of replacement 
alternative methods for use in testing, by 
industry and academia, often with the finan-
cial support of animal welfare organisations 
and/or government funds specifically ear-
marked for this purpose. Until now, the rate 
of progress has been slow, partly because a 
series of barriers must be overcome, in addi-
tion to the legislative/regulatory barrier 
referred to earlier (74). The most important 
of these are the validation barrier and the 
scientific barrier. 
The validation barrier 
The validation of new tests and testing 
strategies in terms of assessing their rele-
vance and reliability is difficult, and the hur-
dles placed in the path of replacement 
alternatives must necessarily be high, if mis-
takes are to be avoided which could have dis~ 
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astrous human health and environmental 
consequences and thus delay the achieve· 
ment of our objectives (75). However, these 
hurdles must be fair, especially as the ani-
mal tests we are seeking to replace have not 
themselves been subjected to formal, inde-
pendent and objective evaluation in terms 
of their relevance, reliability and applicabil-
ity. Validation should be seen as a continu-
OllS process, and the principles and criteria 
involved and the correct practices to be fol-
lowed are still being debated (18, 73, 76), 
One of the greatest problems in planning 
validation studies in the area of toxicity 
testing is finding in vivo data of sufficiently 
high quality for use in evaluating the pre-
dictive value of the results obtained in in 
vitro tests. This has led to recommendations 
that an International Reference Chemical 
Data Bank be established 06, 77), to pro-
vide open-access listings of chemicals, 
backed by first-class toxicological data 
reviews, safety advice and a source of chem-
icals of known purity. The European Centre 
for the Ecotoxicology and Toxicology of 
Chemicals (ECETOC) has established task 
forces for providing chemicals for use in val-
idation studies on alternatives to the Draize 
eye and skin irritation/corrosivity tests (for 
example, 78). The US National Toxicology 
Program (NTP) publishes the results of all 
of its studies, both electronically on the 
Internet and in book form. 
Of course, the most appropriate way to 
assess a new in vitro method is not neces-
sarily to use in vivo data from laboratory 
animals as the reference standard, but to 
compare results from both methods to those 
obtained in human (clinical) studies. 
Unfortunately, finding human data of suffi-
cient quality is a major problem, and those 
data which do exist are often proprietary. 
Moreover, generating new human data is 
fraught with ethical and logistical consider-
ations. 
The scientific barrier 
Replacement alternative methods must be 
based on good science, and extravagant 
claims which cannot be substantiated must 
not be made about them. One of the most 
fascinating sections of Russell and Burch's 
book is their discussion on the relative mer-
its of fidelity and discrimination models (2). 
High fidelity models, as exemplified by the 
use of rodents and other laboratory mam-
mals in toxicity testing, are used because 
"in their general physiological and pharma-
cological properties" they are "more consis-
tently like us than are other organisms". 
High discrimination models, on the other 
hand, "reproduce one particular property of 
the original, in which we happen to be inter-
ested". The Limulus amoebocyte lysate 
(LAL) test is one such model. The use of dis-
crimination models in toxicity testing, for 
example, is represented by the currently 
available in vitro systems and other replace-
ment alternatives, which are more suitable 
for answering a specific question about the 
mechanism of a toxic effect or toxic 
response in a particular cell type than for 
answering the more general question: «Is 
this chemical likely to be toxic in ways 
which we cannot envisage?" 
Russell and Burch warned of the high 
fidelity fallacy and of the danger of expect-
ing discrimination in particular circum-
stances from models which show high 
fidelity in other, more general, terms (2), 
They pointed out that the fidelity of mam-
mals as models for man is greatly overesti-
mated, and concluded that the assumption 
that "mammals are always the best models" 
for man "is maintained with special stub-
borness in some special fields (such as that 
of toxicity testing)". They went on to say 
that the most important consequence of the 
high fidelity myth is that it "ignores all the 
advantages of correlation ", whereby "the 
responses of two utterly different systems 
may be correlated with perfect regularity", 
despite other differences between them. 
The argument about fidelity, discrimination 
and correlation test systems is still going on 
today. 
Ultimately, there is only one way forward 
- the development and acceptance of 
replacement alternatives for both research 
and testing must be based on a sufficient 
understanding of the molecular and cellular 
mechanistic basis of what is being studied 
or measured, i.e. on sound science. Hence, 
the current trend toward a more mechanis-
tic approach should be welcomed, ·encour~ 
aged and financially supported. 
Several specific recommendations relat-
ing to the development and use of replace-
ment alternatives in production and testing 
are given at the end of this report (see 
Conclusions and Recommendations). 
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Education and Training 
The successful implementation of the Three 
Rs heavily depends upon the e~ucation at;d 
training of those persons Involved. l~ 
research and testing. A distinction must InI-
tially be made between "education" and 
"training". Education is defined here as the 
didactic presentation of the information and 
theories of animal use that will contribute to 
the development of proper attitudes toward 
the use of animals in scientific procedures. 
Training is defined as the acquisition ofprac-
tical knowledge and skills directly associated 
with animal handling and procedures. Both 
education and training are necessary for the 
implementation of all of the Three Rs. . 
The objective of the educatIOn and tram-
ing is to provide sufficient information to 
allow scientists to conduct animal proce-
dures to high standards of both science ~nd 
animal welfare, following proper evaluatIOn 
of the scientific and ethical considerations 
which should govern the use of alliaborat?ry 
animals. All people involved in performmg 
animal experiments should have appropriate 
practical training, to help ensure that they 
are technically competent to carry out the 
procedures. Most countries require that 
those conducting animal research be compe-
tent and trained in the techniques that they 
are using or plan to use. Training for those in 
professions that require expe~tise in animal 
handling should he accomplished through 
apprenticeships (that is, "on-the-job" train-
ing) and, in such cases, animals sh?uld o~ly 
he used in order to perfect speCIfic skIlls 
which cannot be achieved in any other way. 
The education and training should con-
tribute to a scientist's ability to design exper-
iments properly and to plan research 
strategies, to become competent in ~ni~al 
handling and the performance of sCIentIfic 
procedures, to make decisions with re.gard to 
the ethics of using animals in experIments, 
and to determine whether alternatives are 
available. The concept of refinement alterna-
tives and the obligation to make them pub-
licly ~vailable, should also be emphasised in 
education and training programmes. 
The workshop participants identified five 
separate groups for which education and 
training are necessary: 
a) animal technicians; 
b) scientists, including laboratory animal 
veterinarians; 
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c) directors of animal facilities and animal 
welfare officers; 
d) national and regional inspectors; and 
e) members of ethics committees/IACUCs 
(scientists and lay representatives). 
Course content a.nd format 
The type of education and training referred 
to below is intended primarily for students 
preparing for an advanced degree in biom~d­
ical research. Such courses should emphaSise 
that the aim of the training is to improve sci-
entific quality as well as to educa~e scientists 
with respect to the legal reqUlrem~nt for 
using alternatives, whenever posslble. ~ 
description of the course on ammal experI-
mentation and alternatives currently offered 
at Utrecht University in The Netherlands 
has been published recently (79). In addition, 
the Federation of European Laboratory 
Animal Science Associations (FELASA) 
Working Group on Education in Europe, and 
the National Research Council in the USA, 
have published guidelines for the education 
and training of persons working with lab~ra­
tory animals (80, 811. All of these publica-
tions serve as excellent prototypes for the 
development of courses in other countries. 
There are several ways in which a course 
on animal experimentation and alternatives 
can be packaged. The first is the standard 
written syllabus with accompanying refer-
ence materials (for example, 82). 
Demonstration videos can also be used. 
Other possible formats include interactive 
CD-ROM and the Internet, the use of both of 
which is becoming more widespread. These 
latter two formats have the potential to 
reach a greater number of scientists. 
Education in ethology 
It is clear that the progress of implementing 
reduction and refinement alternatives 
depends largely on the ability of scientists to 
observe and understand the behaviour and 
needs of their laboratory animals. At pre-
sent it would seem that many experimenters 
are ~s lacking in ethological equipment as 
they are in statistical knowledge .. Fo: ex~n:­
pie, many experimenters have an mdlscnml-
nate reaction to work with mazes, some 
regarding it as harmless and some as stress-
ful. In fact, if a rat is put in a maze when not 
particularly hungry, he is given an .interest-
ing opportunity to exercise the speCIal talent 
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of his species, that of making a cerebral map 
of his spatial surroundings. Such a rat, 
exploring the maze thoroughly, will learn it, 
so that later, if the maze is altered, he can 
soon spot new blind alleys or short cuts. If a 
rat is put in a maze when severely hungry, 
he will run it with anxiety and distress, 
becoming conditioned to one route and stick· 
ing to it thereafter, even when conditions are 
changed and it no longer leads to reward. 
These two cases have been used as classical 
examples of relaxed and stressful behaviour, 
respectively, by Russell (83). 
One very useful guideline for mammalian 
behaviour supplied by ethology is this: any-
thing that leads to learning is harmless or 
positively enjoyable; anything that leads to 
conditioning involves some stress and, there· 
fore, distress. A very effective short course in 
ethological observation was designed some 
years ago for medical students by Chance & 
Mackintosh (84). It originally required the 
use of two rats, but could easily be adapted to 
a video. 
Replacement alternatives in education 
Students should not be forced to use animals 
for any purpose. Replacement alternatives 
for use in education have been described by 
Fosse (85). These include models, films and 
videotapes of procedures, interactive com· 
puter programs, software simulations, 
courseware on compact discs and interactive 
laser discs, and virtual reality programs. The 
NORINA database contains information on 
those alternatives which are available (86). 
Resources are required to produce these 
materials and to make them more widely 
available. 
Informing Scientists about the Three 
Rs Concept 
The use of the term alternatives to encom· 
pass all of the Three Rs is now widely 
accepted in many countries, and is incorpo· 
rated into the names of various centres, for 
example, CAAT, ECVAM and the NCA, and 
journals, such as AATEX (Alternatives to 
Animal Testing and Experimentation -
Japan), ALTEX (Alternativel! zu 
Tierexperimenten - Switzerland), TAR (The 
Alternatives Report - USA), and ATLA 
(Alternatives To Laboratory Animals - UK). 
However, some scientists see its use as being 
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driven by political and social forces exclu· 
sively, rather than being relevant to scien· 
tilic issues (71). This is partly due to a lack of 
appreciation of the basis of the Three Rs con· 
cept as proposed by Russell and Burch, i.e. 
that scientific excellence and the greatest 
humanity in the use of laboratory animals 
are inextricably linked, and of the great 
potential value of alternative methods (87), 
It also stems from a defensive attitude 
among some scientists, perhaps resulting 
from the campaigns of some antivivisection 
organisations and from insufficient dialogue 
among the scientific and animal protection 
communities (88). 
Scientists should be better informed about 
the Three Rs concept, and should be encour· 
aged to see it as an opportunity, rather than 
as a threat. At the conclusion of their book, 
Russell and Burch expressed the hope that 
experimenters would be stimulated "to 
devote special attention to the subject ... to 
work in full awareness of its existence and 
possibilities"(2L For some, including the par· 
ticipants in this workshop, the Three Rs has 
become a subdiscipline within the biological 
sciences, but this is not generally recognised. 
Such recognition should be encouraged and 
promoted through scientific societies, acade· 
mic journals and funding agencies. Various 
governments have already given a lead, by 
creating such bodies and centres as ECV AM, 
ICCV AM and ZEBET, the German Federal 
Government's Centre for Documentation 
and Evaluation of Alternative Methods to 
Animal .Experiments. The journals specifi· 
cally devoted to the Three Rs, such as 
AATEX, ALTEX, TAR and ATLA, should be 
made more readily available to scientists by 
their institutional libraries. 
Informing the General Public 
Although many members of the general pub-
lic are concerned about the use of animals in 
research, testing and education, it is clear 
that they are not typically well-informed 
about the Three Rs approach to th~ ethical 
issues raised by animal experimentation. 
There are several reasons for this: the Three 
Rs approach has not been embraced by many 
of the protagonists in the vivisection contro· 
versy (neither scientists nor animal protec· 
tionists); some individuals and organisations 
who have embraced the Three Rs have not 
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made a point of informing the public of this 
approach; and those who have made the 
effort have often found the media unrecep-
tive, preferring instead to portray confronta-
tions between those holding diametrically 
opposed views. Indeed, it is easier for all con-
cerned to convey a message in the form of 
simple slogans, such as Stop Animal 
Experiments (89) or Most People See a Rat-
We See a Cure {or Cancer (90), than it is to 
explain the principles of reduction, refine-
ment and replacement as a blueprint for ree-
oncili ng the interests of science and animal 
welfare. 
Why should supporters of the Three Rs 
consider informing the public about this 
approach? Their efforts can reach members 
of the public who are sympathetic, and who 
can then offer moral, financial and political 
support to the cause. We know that members 
of the general public are hearing about more 
confrontational approaches to the animal 
research controversy; unless they also hear 
about the Three Rs, our approach will be per-
ceived as being irrelevant to this issue. 
Many organisations concerned with pro-
moting the Three Rs have sought to inform 
the public about their activities, and about 
the alternatives approach in general (for 
example, 91 J. These efforts have entailed 
producing leaOets, brochures and other writ-
ten material (92); taking advantage of media 
opportunities to appear on radio or television 
programmes, or in print; speaking to stu-
dents and community groups; and placing 
advertisements. The Internet is providing 
organisations with a new opportunity to 
make their message widely and freely avail-
able. An unexplored possibility is for one or 
more organisations to independently pro-
duce a high quality video programme, which 
can be shown on educational television sta-
tions and be distributed to interested indi-
viduals and organisations. 
Past efforts· to inform the general public 
about the issues relating to alternatives have 
had mixed outcomes. Accordingly, pro-alter-
natives organisations should devise and 
implement such efforts carefully, with due 
consideration to past successes and failures. 
Perhaps the most important specific tar-
get audiences within the general public are 
teachers and students in schools and col-
leges. In the UK, there has been a surge of 
interest since animal experimentation 
became a subject in secondary (high) school 
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social studies and biology syllabuses. This 
has led many organisations to produce spe-
cial publications, and FRAME was invited by 
an educational publisher to produce two 
booklets to convey an objective, middle-
ground position on animal experimentation 
and on alternatives (93, 94). With the sup-
port of industrial companies, a copy of each 
booklet was given free of charge to every sec-
ondary school in Britain. It is particularly 
important that material for schools and col-
leges should be designed to help young peo-
ple make up their own minds on this issue 
(the approach adopted, for example, in the 
newsletter GAATALYST, which is produced 
by GAAT for 11-14 year olds), rather than to 
seek to persuade them. In addition, while 
more-detailed material might usefully be 
provided for teachers, care should be taken 
not to be seen to want to instruct them in 
how to teach their subjects. 
One very successful way for organisations 
to encourage individual students to become 
actively involved in the Three Rs is the pro-
vision of support for temporary employment 
in laboratories or in the offices of the organ-
isations themselves. Replacement alterna-
tive methods can be very suitable for 
undergraduate, as well as graduate, research 
projects. 
There are occasions when concerted action 
by groups of organisations with similar 
philosophies and policies could be the best 
way of getting a message across to a large 
audience. For example, advertisements could 
be placed in newspapers or magazines in the 
light of specific events. Organisations which 
were willing to join in such concerted actions 
might also agree on a common logo, which 
would become more widely recognised the 
more it was used. 
Special Considerations 
Vaccines and other immunobiologicals 
The development, production and quality 
control of vaccines and other immunobiolog-
icals was recognised as being an important 
area for the implementation of the Three Rs, 
since large numbers of animals are used 
which usually suffer significant pain and dis· 
tress as a result of the experimental proce· 
dures employed. Most of the animal tests 
undertaken are documented in either a com-
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pendium, such as the European 
Pharmacopoeia, or in guidelines produced by 
national control authorities and interna-
tional regulatory bodies (for example, by the 
World Health Organisation), as well as in 
national product licences. 
For a variety of reasons, interest in both 
the Three Rs and in vaccine quality control 
strategies has grown in the past decade. This 
has led to a reduction in the use of animals 
for vaccine quality control purposes. Reviews 
of recent developments, and recommenda-
tions for further initiatives, have been pub-
lished (95, 96). 
Steps should be taken to facilitate further 
implementation of the Three Rs concept 
with respect to the development, production 
and quality control of immunobiologicals, 
especially in relation to testing require-
ments. Potency tests based on a challenge 
procedure are of particular concern. Lethal 
endpoint potency tests for tetanus and diph-
theria vaccines are still documented in some 
pharmacopoeias, and are therefore still per-
formed in some countries, although alterna-
tive non-lethal endpoint tests are also 
permitted and are widely used by more 
advanced countries. Lethality endpoints 
should be replaced with other assessment 
measures. Validated in vitro test systems, 
such as enzyme-linked immunosorbent 
assays (ELISAs) or serological systems based 
on in vitro models, should be employed, to 
reduce and refine the use of animals. When 
challenge of experimental anim.als is 
unavoidable, clear clinical symptoms should 
be taken as being equivalent to the lethality 
endpoint, and animals showing such symp-
toms should then be killed humanely (951. 
A proposed alternative approach for esti-
mating potency (97) should be evaluated. In 
this approach, a distinction is made between: 
a) estimation of the immunogenic potency of 
the first few batches obtained from a seed 
lot; and b) monitoring the consistency of sub-
sequent batches. The use of animals is lim-
ited to the first few batches, while 
monitoring the consistency of the quality of 
subsequent batches is undertaken by using 
in vitro methods (971. 
Although there is no in vitro model avail-
able for replacing the Abnormal Toxicity 
Test in vaccine safety testing, the value of 
this test is questionable, since its lack of 
specificity hampers reliable interpretation of 
the results obtained (95). Efforts should also 
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be made to minimise the numbers of mice 
used for pertussis vaccine testing by standar-
dising the procedures employed. 
It was emphasised that the development of 
reduction, refinement and replacement 
alternative methods is the responsibility of 
all those involved in the production and qual-
ity control of vaccines and other immunobio-
logicals (that is, both industry and 
governm€mt). 
Transgenic animals 
The production, breeding and lise of animals 
genetically modified via the application of 
transgenic techniques will undoubtedly 
increase significantly in the future. This new 
technology offers great potential scientific 
benefit, in terms of the understanding of 
fundamental biological processes, the 
nature, diagnosis and treatment of various 
diseases, the production of useful biological 
products, and the husbandry of disease-resis-
tant animals. Animal transgenesis may also 
contribute to the implementation of the 
Three Rs, by reducing animal numbers, by 
permitting the replacement of more-sentient 
species with less·sentient species, by reduc-
ing animal suffering in other ways, and by 
increasing the relevance of laboratory ani-
mal use. For example, in the USA, several 
transgenic mouse models are currently being 
investigated by the NTP with respect to 
their usefulness in evaluating the potential 
carcinogenicity and mutagenicity of chemi-
cals (98). Carcinogenicity studies employing 
these models are completed in six months or 
less, compared with the standard two-year 
bioassay, and involve fewer animals per dose 
group. In addition, the animals are not sub· 
ject to age-related morbidity and mortality. 
Despite these kinds of developments, some 
observers are of the opinion that the use of 
transgenic animals will lead to an overall 
increase in animal use, rat-her than to a 
decrease. There is also legitimate concern 
that the control of the production, breeding 
and use of transgenic animals is not ade-
quately provided for in current legislation for 
the protection of laboratory animals. For 
example, there is as yet no broad agreement 
on whether only the creation of transgenic 
animals, andlor their breeding, and/or their 
use in specific experiments should be treated 
as regulated procedures, or whether trans-
genic animals should be protected through-
out their lives, whether or not they are ever 
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used in specific experiments. The system 
adopted in the UK, whereby strict controls 
are applied to the breeding of transgenics 
until it can be shown that no special health 
and husbandry problems are involved, is to 
be recommended. 
Molecular geneticists involved in produc~ 
ing transgenic animals must always be aware 
of the animal welfare implications of their 
experiments, and of their legal and moral 
responsibilities (99, IDOl. Concern that this 
is not always the case has been highlighted 
by the occurrence of unexpected, sometimes 
very severe, adverse effects in transgenic ani M 
mals. There are also ethical concerns about 
transferring genes between species, particu-
larly when the genes involved are human 
genes (101). Moore & Mepham (102) have 
suggested recently that the actual and poten-
tial implications of the increased use of 
transgenic animals may result in the need 
for a fundamental reappraisal of the mecha· 
nisms whereby permission to perform scien· 
tific procedures on animals is considered and 
granted. 
Special protection for selected animals 
A fundamental tenet of the refinement prin· 
ciple is that the least sentient species suit· 
able for the proposed experimental work 
should always be selected. However, there is 
no general agreement on how sentience can 
be measured or how degrees of sentience can 
be compared. For example, is a marmoset 
more sentient than a rat? In some legisla· 
tion, 'Special consideration is given to non· 
human primates, cats and dogs. In Britain, 
this special consideration is also extended to 
Equidae. It can be argued that there are two 
different justifications for this approach. 
Firstly, in the case of the higher primates 
(Old World monkeys and Hominids), what-
ever is meant by "sentience" or, in the words 
of Directive 86(609(EEC, "degree of neuro-
physiological sensitivity"(12), it is commonly 
accepted that these animals are placed at the 
top end of any spectrum or scale. They there-
fore deserve special consideration, both in 
their own right, and also because, if we can· 
not ensure the proper application of labora-
tory animal protection laws and regulations 
to them, we are unlikely to be successful in 
providing adequate care for rodents, birds 
and fish. 
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Secondly, cats, dogs and horses have been 
bred over many centuries to be companion 
animals for human beings, and it can be 
argued that, since they have been bred to be 
dependent on us, we have a specific moral 
obligation to them. That is certainly how the 
vast majority of members of the general pub-
lic would be likely to view the situation, and 
both animal experimentation and the Three 
Rs must be viewed in a social, as well as in a 
scientific, context. Nevertheless, there is a 
strong counter-argument that all laboratory 
animals should be given equal protection, 
and that all forms of speciesism should be 
avoided. 
Benefit and suffering! 
It is implicit, if not explicit, in all the regula-
tions governing laboratory animal use that 
the purpose of the work must be worthwhile, 
and that it must be viewed in relation to the 
suffering caused to the animals used. 
The British 1986 Act requires that the 
likelihood of a beneficial outcome of a pro-
posed programme of work is assessed in 
advance, and that, where it would involve 
vertebrate animals which might be caused to 
suffer pain, distress and/or lasting harm, a 
weighing of likely benefit versus likely suf-
fering must be made, before permission is 
given for the experimental work to proceed 
(16,27, 103). 
Cost-benefit apaIysis is part of our every-
day lives, and it involves judgement on the 
basis of evidence, rather than automatic 
decisions based on precise measurements. 
Applying this kind of approach should not be 
new to scientists, since it is an essential part 
of the peer· review system for granting 
research funding. 
Who should be involved in assessing and 
weighing benefit and suffering will depend 
on the particUlar system for regulating ani-
mal experimentation. The ultimate moral 
responsibility should lie with the scientists 
who propose to perform the studies. 
However, institutions, funding agencies, gov-
ernments and the community in general 
should all have some input (27). In the UK, 
the Home Office Inspector would discuss this 
question with a project licence appJicant, and 
would advise the Home Secretary, with 
whom the ultimate legal responsibility lies 
I The word "suffering" has been used as a generic term for "undergoing, experiencing or being subjected to pain, 
distress and lasting harm n. 
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(104). In other countries, IACUCs or ani-
mal ethics committees contribute to the 
discussion or even make decisions. 
This is a topic which deserves further 
consideration, especially with respect to 
the ways in 'which benefit and suffering 
should be assessed and weighed. Four 
main schemes have been proposed or are 
in use: that suggested in Lives in the 
Balance, the report of the Institute of 
Medical Ethics (UK) Working Party (27); 
the Dutch model developed by the 
Department of Animal Problems, Leiden 
University (105); a model proposed by 
Porter (106); and the system already used 
by the British Home Office Inspectorate 
for the assessment and weighing of bene· 
fit and suffering, which was described in 
the 1993 report of the APC (107). 
It is widely agreed that there are levels 
of animal suffering which could never be 
justified on scientific grounds, but there 
is no agreement as to what those levels 
are. It is certainly possible to perform 
procedures in one country which would 
not be permitted in another. This is a 
matter which deserves urgent interna· 
tional discussion and agreement. 
The setting of targets 
One way of making progress is to agree 
that specific targets should be met, espe-
cially if a date for meeting a target is also 
agreed. Whether or not a target is met, 
the fact that it exists can influence policy 
and stimulate action, as has been seen in 
response to the Sixth Amendment 
(Directive 931351EEC [108)) to the 
European Union (EU) Cosmetics 
Directive, Directive 7617681EEC (109, 
110). 
In 1993, the Member States of the EU 
agreed that everything possible should be 
done to achieve a reduction of 50% in the 
use of vertebrate animals for experimental 
and other scientific purposes by the year 
2000 (l1ll. It has also recently been sug-
gested that agreement should be sought in 
the EU on phasing out the use of non-
human primates as laboratory animals by 
the year 2005 (112). Further targets which 
could be suggested would be an end to 
potency and toxicity tests involving lethal 
endpoints, to the use of the Draize eye 
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irritancy test, and to all procedures which 
result in substantially severe effects. 
Concluding Remarks 
The workshop participants unanimously 
reaffirmed the principles put forward by 
Russell & Burch (2), that humane science is 
good science and that this is best achieved 
by vigorous application of the Three Rs: 
reduction alternatives, refinement alterna· 
tives and replacement alternatives. Thus, 
the only acceptable animal experiment is 
one which uses the smallest possible number 
of animals and causes the least possible pain 
or distress which is consistent with the 
achievement of a justifiable scientific pur· 
pose, and which is necessary because there 
is no other way of achieving that purpose. 
Any proposed experiments on animals 
should be subjected to prior and effective 
expert review by an ethics committee or an 
equivalent body. The Three Rs should be 
seen as a challenge and as an opportunity 
for reaping benefits of every kind - scien· 
tific, economic and humanitarian - not as a 
threat. 
It was proposed that, if funds could be 
obtained, an animal welfare information 
unit for Europe should be established at 
Sheringham, under the direction of Rex 
Burch; this would liaise with the corre· 
sponding centre in the USA. Such an initia-
tive could help meet some of the specific 
recommendations made in this report. as 
well as playing an important role in the edu-
cation of the general public. 
It was agreed that contact would be main-
tained by the workshop participants, and 
that a further meeting of the Sheringham 
Group would take place on the occasion of 
the Second World Congress on Alternatives 
and Animal Use in the Life Sciences, to be 
held in Utrecht in October 1996. One of the 
principal aims of this meeting will be to 
review the steps taken by the participants in 
the workshop, individually and collectively, 
to see that its report and recommendations 
have been publicised and implemented. In 
addition, it was agreed that an informal 
meeting of societies and organisations com-
mitted to the implementation of the Three 
Rs should be arranged at the Second World 
Congress, with a view to the possible forma-
tion of an international federation. 
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Conclusions and Recommendations 
General 
1. Existing laboratory animal protection 
laws should be fully implemented. 
2. All countries should have a legal frame-
work which actively incorporates the 
Three Rs into all animal-based research, 
testing and education. 
3. There should be formal and informal 
mechanisms for the education and train-
ing of academic, industrial and govern-
ment scientists and officials in the Three 
Rs, to ensure compliance with the spirit 
and letter of laboratory animal protec-
tion legislation and regulations. 
4. Before proposing any programme of 
work involving laboratory animals, sci-
entists should ask themselves whether 
the project is worth doing in the first 
place, and, if so, whether the problem 
could be approached in a different way, 
for example by using in vitro methods or 
animals of lower sentience. 
5. Any proposed experiments on animals 
should be subjected to prior and effective 
expert review, both for scientific merit 
and animal welfare considerations. All 
scientists and institutions concerned 
should take steps to ensure that proposed 
programmes of work involving animals 
which do not have to pass through an 
external peer-review process are never-
theless subjected to effective evaluation 
for scientific merit and necessity. 
6. Institutions should be required to 
appoint one or more persons responsible 
for ensuring that the Three Rs are fully 
taken into consideration when pro-
grammes of work on animals are pro-
posed and during the experimental work 
itself. 
7. It should be recognised that the assess-
ment and weighing of the likely benefit 
and likely animal suffering involved in a 
proposed programme of work is an 
essential part of the process whereby 
permission for the work to proceed is/is 
not granted. Further studies should be 
undertaken on how this assessment and 
weighing could be conducted, as a basis 
for international agreement and har-
monisation. 
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8. There should also be international dis-
cussion and agreement on what levels of 
animal suffering should not be permit-
ted in any circumstances, regardless of 
any likely or potential benefits. 
9. It is the responsibility of the investigator 
to choose and justify, on scientific and 
animal welfare grounds, the animal 
species and strain which is most suitable 
for the proposed investigation. 
10. It is unacceptable to export scientific 
work involving laboratory animals to 
avoid scientifically realistic, but more 
stringent, animal welfare codes. 
11. Discussions should be encouraged at the 
national and international level with a 
view to setting targets and time limits 
for the achievement of specific goals in 
the reduction, refinement and replace-
ment of the use of vertebrate animals in 
experiments and other scientific proce-
dures. 
12. There is a need for the involvement in 
animal welfare issues of more people 
with initial training in the life sciences 
and postgraduate training in 
biometry/statistics. 
Reduction altenwtives 
13. In cases where a choice between species 
is possible, tHere is generally no scien-
tific justification for using more of the 
smaller species than of the larger one. 
14. Research strategy should be considered 
carefully, with a view to reducing the 
numbers of animals used. The example 
of Hendriksen ef al. (32), in choosing 
strains of laboratory mice in order to 
minimise the numbers needed in specific 
biological assays, should be followed for 
those assays which use large numbers of 
animals and which are unlikely to be 
replaced with in vitro alternatives in the 
near future. 
15. The design of regulatory testing proce-
dures, including the sample sizes 
required, should be reviewed regularly, 
possibly as part of international harmon-
isation. 
16. Substantial reduction in animal use 
could be achieved by further harmonis-
ing toxicity testing regulations, for 
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example, with respect to group sizes, 
dose levels and the length of studies. 
17. In view of the uncertainties inherent in 
"extrapolating" to humans, the need for 
very high precision in data provided by 
animal experiments should be reconsid· 
ered. 
18. There is evidence that some non· regula-
tory animal experiments are poorly 
designed an~ incorrectly analysed. As a 
minimum, all research workers should 
have adequate training in experimental 
design and the proper use of statistical 
methods. 
19. The concept of the "named statistician" 
as an essential part of the regulatory 
framework of animal experimentation 
should be explored. 
Refinement alternatives 
20. An international data bank on refine-
ment alternatives should be developed. 
21. The validation process should include 
the evaluation of refinement alternative 
procedures, particularly in relation to 
regulatory testing. 
22. There should be internationally agreed 
guidelines for the categorisation of ani-
mal pain, distress and other adverse 
effects, including agreement on physio-
logical and behavioural signs for the 
recognition of adverse effects and for 
their measurement. 
23. Working parties should be set up, on an 
international, collaborative basis, to 
develop codes of practice and guidelines 
of best practice for specific animal hus-
bandry (welfare) and research proce· 
dures. When such codes and guidelines 
have been developed and agreed, adher-
ence to them should be mandatory. 
24. Individuals and institutions should be 
responsible to their national authorities 
for prospective and retrospective assess-
ments of the nature and levels of adverse 
effects likely to be experienced or actu· 
ally experienced by animals in each pro-
gramme of work. 
25. Research on refinement and welfare 
aspects should be encouraged and 
funded, including studies on the effects 
of minimising pain and distress on the 
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quality of research data. 
26. Journal editors should be encouraged to 
include a separate consideration of 
Animals and Procedures within the 
Materials and Methods section of the 
articles they publish. 
Replacement alternatives 
27. Statistics on animal use should include 
the numbers of animals killed specifi-
cally for the purpose of providing cells 
and tissues for in vitro studies. 
28. In the case of regulatory efficacy and 
toxicity testing, research specifically 
aimed at providing validated replace-
ment alternatives for the currently 
accepted animal procedures should be 
conducted. 
29. The development and acceptance of 
replacement alternatives for both 
research and testing must be based on 
an understanding of the molecular and 
cellular mechanistic basis of the phe. 
nomenon being studied or measured. 
The current trend toward a more mech-
anistic approach should be welcomed, 
encouraged and financially supported. 
30. Monoclonal antibodies should only be 
produced by using in vitro methods, 
unless a convincing scientific case can be 
made for using the mouse ascites tech-
nique. 
31. New in vitro methods for the production 
of hormones and other biological prod~ 
ucts, which would result in purer prep-
arations, should be sought. Efforts 
should be made to determine whether in 
vivo bioassays for the safety and efficacy 
testing of hormones and related prod-
ucts can be replaced by using a combina~ 
tion of physicochemical and in vitro 
tests. 
32. The animal welfare and ethical issues 
pertaining to the procurement of fetal 
and neonatal calf sera should be investi-
gated. The development of fullJ defined 
substitutes which could replace the use 
of serum when culturing cells should be 
encouraged. 
33. Since it is unlikely that an animal test 
could be replaced with a single in vitro 
test, the development, evaluation and 
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optimisation of testing strategies and 
integrated testing schemes should be a 
high priority. 
34. Human cells and tissues should be used 
in preference to those isolated from lab-
oratory animals whenever possible. 
However, it is recognised that there are 
ethical, safety, legal and logistical prob-
lems which may prevent the widespread 
use of human tissues. 
Educahon and training 
35. A clear distinction needs to be made 
between education which aims to con-
tribute to the development of proper 
attitudes toward the use of animals, and 
the training of individuals who will be 
practicalIy involved in animal experi-
mentation itselC be it by conducting 
experiments, by contracting or permit-
ting experiments, or by caring for the 
animals used. 
36. The responsible authorities should 
require that all those with any practical 
involvement should take accredited 
courses which em phasise the importance 
of all of the Three Rs, and the legal 
requirement to use alternatives when-
ever possible. Emphasis should be placed 
on "best practice", for the sake of both 
8cientific quality and the welfare of the 
animals used. 
37. Permission to conduct experimental pro-
cedures on animals should be based not 
only on general training, but also on spe-
cific training and evidence of compe-
tence, which should be reassessed 
regularly. 
38. A Three Rs education and training data-
base should be established, so that all 
concerned can have easy access to infor-
mation and advice on the availability of 
relevant literature. 
39. School students and undergraduates 
should not be forced to conduct proce-
dures on animals as part of their 
courses, but, should, where necessary, be 
provided with alternative options. 
Informing scientists about the Three Rs 
concept 
40. National, regional and international cen-
tres should be established to facilitate 
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and promote research and the imple-
mentation of the Three Rs through fund-
ing and education. These centres should 
be networked, to facilitate coordination 
and information exchange. 
41. Government, industrial and academic 
scientists should be encouraged to 
become involved to a greater extent in 
the development, validation and imple-
mentation of alternative methods. 
42. Funding agencies should allocate funds 
specifically for research on all of the 
Three Rs. 
43. The concept and availability of the Three 
Rs, in the context of excellence and 
humanity in scientific research, should 
be incorporated into graduate education 
and into training programmes which 
also cover experimental design, animal 
welfare issues and statistics. 
44. The editors of appropriate academic 
journals should be encouraged to intro-
duce regular and specific consideration 
of progress in the Three Rs in relation to 
the subject areas covered by their jour-
nals. 
45. The officers of learned societies should 
be encouraged to establish subdisci-
plines within their organisations to con-
sider the Three Rs aspects of their 
disciplines, thereby encouraging recogni-
tion of the scientific and humanitarian 
importance of the Three Rs concept. 
Informing the general public about the 
Three Rs 
46. Organisations concerned in promoting 
all types of alternative methods should 
devote some of their energies to inform-
ing the general public of the nature and 
importance of the Three Rs approach. 
47. Such organisations should consider joint 
efforts, as a means of improving quality, 
avoiding pitfalls, and sharing costs. 
When appropriate, concerted advertis-
ing, mailings and other actions should be 
devised and implemented, to take advan-
tage of timely, high profile issues, 
whether to encourage positive develop-
ments or to forestall negative develop· 
ments. 
48. Priority should be given to providing 
materials for teachers. 
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49. Organisers of workshops, conferences 
and other meetings on the Three Rs, 
should, when appropriate, consider pub-
licising the outcome of such meetings. 
Lay summaries of the proceedings of 
meetings on alternatives should, when 
appropriate and feasible, be published. 
Special considerations 
50. Animal welfare considerations should be 
an essential part of the evaluation of the 
acceptability of proposed new regulatory 
test guidelines, or modifications of exist-
ing guidelines. 
51. When a new regulatory test guideline 
has been accepted, which involves fewer 
animals or less animal suffering, it 
should not be optional, but should be 
required in preference to any other 
method. 
52. Wherever possible, quantitative end-
points should be used. Death and other 
qualitative endpoints are often inhu-
mane, and provide less information than 
quantitative measurements. It is inex-
cusable to use lethal endpoint acute tox-
icity tests (for example, LD50 tests), 
when a non-lethal endpoint test (for 
example, the Fixed Dose Procedure) has 
been formally accepted as an alternative 
OEeD test guideline method. 
53. When challenge of experimental animals 
is unavoidable as, for example, in vaccine 
potency testing, clear clinical symptoms 
should be taken as being equivalent to 
the lethality endpoint, and animals 
showing such symptoms should then be 
killed humanely. 
54. A proposed alternative approach for esti-
mating vaccine potency should be evalu-
ated, which involves limiting the use of 
animals to the first few batches, while 
monitoring the consistency of the qual-
ity 'of subsequent batches by using in 
vitro methods. 
55. Since it is of questionable value, the use 
of the Abnormal Toxicity Test in vaccine 
safety testing should be discontinued. 
56. Urgent consideration should be given to 
the revision of laws and regulations con-
cerning the use of animals, so that, 
where necessary, animals with a delete-
rious phenotype, whether spontaneous 
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or caused by mutagens or transgenic 
techniques, are afforded the same level 
of protection throughout their lives as 
that which would be appropriate had 
that level of suffering been induced by 
any other method or technique. 
57. There should be a review of the systems 
currently used for evaluating the ethical 
acceptability of gene transfer into ani-
mals on a case-by-case hasis, with partic-
ular emphasis on the transfer of human 
genes into animals. 
58. The higher primates, cats, dogs and 
horses should continue to be regarded as 
animals deserving special consideration. 
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